News and Trends 22 Feb 2017 Roche doubles down in Fight against Antibiotic Resistance In 2014, Discuva partnered up with Roche to develop new antibiotics against multidrug-resistant bacteria. The two companies have announced an extension of their collaboration until February 2018. The Cambridge-based company… February 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2022 Healthy volunteer study for tablet to treat brain cancer open for recruitment A clinical stage drug company developing sulforaphane-based medicines for cancer treatment has started recruiting for a pharmacokinetic / pharmacodynamic trial in healthy volunteers (HV). Evgen Pharma plc also announced the… October 20, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2018 Scancell and BioNTech Will Combine Their Expertise to Fight Cancer Scancell has brought in BioNTech to develop T-cell receptors against specific target proteins in cancer cells, opening the door to new cancer treatments that target them. Scancell works on immunotherapies… January 9, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2022 Discovery Park celebrates 10 years and plans to double jobs over the next decade Plans to grow and double the number of people employed at Discovery Park, the UK’s biggest science and innovation center have been announced. The team behind its success shared the… November 16, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 13 Oct 2025 Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle As well as being known for its historical beauty and academic excellence, Cambridge has a reputation as a leading biotech hub, forming part of the U.K.’s “Golden Triangle” with Oxford… October 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2016 This European Biotech Initiative wants to remediate Contaminated Land It has been estimated that the impact of potentially polluting activities has affected around 3 million sites in Europe alone with great risk of adverse human health effects. As a… September 20, 2016 - 5 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 24 Nov 2016 Infographic: The Changing Face of UK Drug Discovery by the Numbers After Brexit, UK pharma is striving to reinvigorate drug discovery through collaboration. This infographic shows why that’s necessary. A new report from the Association of the British Pharmaceutical Industry (ABPI)… November 24, 2016 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jul 2022 Good news for Destiny Pharma’s nasal gel to combat life-threatening infections Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration (FDA) on its XF-73 nasal gel phase 3 development plans…. July 19, 2022 - 5 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 21 Jun 2017 Video: Can Synbio Cure Malaria? – Fireside Chat with Oxitec’s CEO Hadyn Parry In our fireside chat with Hadyn Parry, Clara had the chance to hear all about Oxitec’s exciting technology that could save us from Dengue and Zika. Oxitec’s GM mosquitoes have… June 21, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Interview 6 Sep 2017 The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue Gilead has just splashed out $12 billion for Kite Pharma, and the FDA is currently reviewing Novartis’ Marketing Approval Application for the first-ever CAR-T therapy. I sat down with Gregg… September 6, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Startup Scout 25 Oct 2019 This UK AI Tool Researches Diseases for Drug Discovery Companies The Manchester-based company Biorelate is developing artificial intelligence (AI) technology that can collect biological data from the internet and speed up the drug discovery process. Mission: Develop AI technology that… October 25, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2022 Roquefort Therapeutics buys UK biotech in return for shares Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in return for shares. Oncogeni develops novel patented cancer medicines, and will receive 50 million shares,… June 22, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email